干细胞
药物发现
三维细胞培养
微流控
类有机物
细胞生物学
纳米技术
芯片上器官
细胞
微流控芯片
计算机科学
细胞培养
生物
再生医学
单细胞分析
计算生物学
组织工程
电池类型
诱导多能干细胞
胚胎干细胞
单元格排序
生物信息学
材料科学
遗传学
作者
Jeong Ah Kim,Soohyun Hong,Won Jong Rhee
出处
期刊:World Journal of Stem Cells
[Baishideng Publishing Group Co (World Journal of Stem Cells)]
日期:2019-10-26
卷期号:11 (10): 803-816
被引量:13
标识
DOI:10.4252/wjsc.v11.i10.803
摘要
Although the recent advances in stem cell engineering have gained a great deal of attention due to their high potential in clinical research, the applicability of stem cells for preclinical screening in the drug discovery process is still challenging due to difficulties in controlling the stem cell microenvironment and the limited availability of high-throughput systems. Recently, researchers have been actively developing and evaluating three-dimensional (3D) cell culture-based platforms using microfluidic technologies, such as organ-on-a-chip and organoid-on-a-chip platforms, and they have achieved promising breakthroughs in stem cell engineering. In this review, we start with a comprehensive discussion on the importance of microfluidic 3D cell culture techniques in stem cell research and their technical strategies in the field of drug discovery. In a subsequent section, we discuss microfluidic 3D cell culture techniques for high-throughput analysis for use in stem cell research. In addition, some potential and practical applications of organ-on-a-chip or organoid-on-a-chip platforms using stem cells as drug screening and disease models are highlighted.
科研通智能强力驱动
Strongly Powered by AbleSci AI